Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1993 • 1,119 citations

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

1994 • 868 citations

STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN.¹

1973 • 812 citations

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.

1995 • 741 citations

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

1964 • 693 citations

Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns

1993 • 678 citations

A SENSITIVE, PRECISE RADIOIMMUNOASSAY OF SERUM INSULIN RELYING ON CHARCOAL SEPARATION OF BOUND AND FREE HORMONE MOIETIES

1972 • 634 citations

Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man

1992 • 620 citations

Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients

1995 • 572 citations

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.

1993 • 467 citations

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.

1991 • 371 citations

Biological Effects and Metabolic Rates of Glucagonlike Peptide-1 7–36 Amide and Glucagonlike Peptide-1 7–37 in Healthy Subjects Are Indistinguishable

1993 • 311 citations

Glucagon-like peptide-1, a new hormone of the entero-insular axis

1992 • 290 citations

Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.

1993 • 264 citations

Glucagonlike peptide 1: A newly discovered gastrointestinal hormone

1994 • 258 citations

Pancreatic and intestinal processing of proglucagon in man

1987 • 203 citations

Glucagon-like peptide-1 is a physiological incretin in rat.

1995 • 193 citations

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

1982 • 173 citations

Proglucagon processing in porcine and human pancreas.

1994 • 167 citations

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1983 • 156 citations

Regulation of Intestinal Proglucagon- Derived Peptide Secretion by Intestinal Regulatory Peptides*

1991 • 156 citations

Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy

1991 • 154 citations

Glucagon-Like Peptide-1 7-36 Amide and Peptide YY from the L-Cell of the Ileal Mucosa Are Potent Inhibitors of Vagally Induced Gastric Acid Secretion in Man

1994 • 128 citations

Immunoreactive Gastric Inhibitory Polypeptide*

1988 • 96 citations

Methods in Neurosciences

1991 • 80 citations

Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.

1983 • 74 citations

Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in Man

1980 • 70 citations

Degradation Of Bioactive Substances: Physiology And Pathophysiology

2024 • 60 citations

Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat

1985 • 56 citations

Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation

1993 • 46 citations

Renal effects on serum gastric inhibitory polypeptide (GIP)

1977 • 39 citations

Depression of Insulin Release by Anti-GIP Serum after Oral Glucose in Rats

1981 • 35 citations

Reduced gastric acid inhibitory effect of a pGIP(1–30)NH2 fragment with potent pancreatic amylase inhibitory activity

1992 • 22 citations

Circadian rhythm of gastric inhibitory polypeptide (GIP) in man

1983 • 22 citations

Is GLP-1 amide an endogenous antagonist at GLP-1 receptors?

1994 • 21 citations

Diurnal Variation of Plasma Gastric Inhibitory Polypeptide in Man

1980 • 16 citations

Gut signals for islet hormone release

1990 • 15 citations

The pharmacokinetics of porcine glucose‐dependent insulinotropic polypeptide (GIP) in man

1982 • 14 citations

Cardiac autonomic function in fibrocalculous pancreatic diabetes

1993 • 11 citations

Physiology and pathophysiology of GIP: A review

1991 • 7 citations

Day Profiles of Glucose Dependent Insulinotropic Polypeptide (GIP) in Normal Subjects

1985 • 4 citations

Renal effects of serum gastric inhibitory polypeptide (GIP)

1976 • 3 citations

The reactivity of anti-porcine gastric inhibitory polypeptide (GIF) rabbit serum R65 with synthetic human and porcine GIF

1992 • 2 citations

Cited By (0)

Loading...